Antimicrobial Stewardship Principles and Practice
Antimicrobial stewardship is the coordinated set of activities designed to promote the appropriate use of antimicrobial agents, with the goals of improving patient outcomes, reducing antimicrobial resistance, and limiting the spread of infections caused by multidrug-resistant organisms. As an area within the study of antimicrobial resistance, it links the biology of resistance to the organisational, behavioural, and clinical practices that govern how antimicrobials are selected, dosed, and stopped.
Definition
Antimicrobial stewardship denotes coordinated interventions intended to measure and improve the appropriate use of antimicrobials by promoting the selection of the optimal agent, dose, duration, and route of therapy, in order to achieve the best clinical outcome while minimizing toxicity, the selection of resistant organisms, and unnecessary cost.
Scope
This area orients the reader to stewardship as a discipline: its rationale in the resistance crisis, the core principles that define appropriate prescribing, and the institutional structures that put those principles into practice. It groups the detailed topics on prescribing principles, diagnosis-driven therapy, de-escalation and duration, and program implementation. It frames stewardship as a system-level and educational subject and is not a source of individualized prescribing instructions.
Sub-topics
Core questions
- Why does the way antimicrobials are used drive the emergence and spread of resistance?
- What distinguishes appropriate from inappropriate antimicrobial use?
- Which structures, interventions, and metrics allow an institution to improve prescribing?
- How is the benefit of stewardship to individual patients balanced against its benefit to the wider population?
Key concepts
- Selective pressure of antimicrobial exposure
- Appropriate use (right agent, dose, duration, route)
- Prospective audit and feedback
- Formulary restriction and preauthorization
- De-escalation
- Collateral damage (resistance and Clostridioides difficile infection)
- Multidisciplinary stewardship team
- Stewardship metrics (days of therapy, defined daily doses)
Mechanisms
Every exposure of a microbial population to an antimicrobial exerts selective pressure that favours surviving resistant organisms; reducing unnecessary or excessively broad and prolonged exposure is therefore the central lever by which stewardship slows resistance. Stewardship programs translate this principle into action through a small number of evidence-supported interventions, of which prospective audit with feedback to prescribers and formulary restriction with preauthorization are the two core strategies, supported by guideline development, education, and the integration of microbiology and pharmacy data into prescribing decisions.
Clinical relevance
Stewardship sits at the interface of microbiology, pharmacology, and health-system practice, and understanding it is part of evidence appraisal and infection-prevention literacy across the health sciences. Systematic reviews indicate that stewardship interventions can increase guideline-concordant prescribing and shorten unnecessary therapy without harming patients, and can reduce resistant infections and Clostridioides difficile rates. This entry describes how those system-level effects are studied and is not a basis for individual diagnostic or treatment decisions.
Epidemiology
Antimicrobial resistance is a global public-health threat that is propelled by the volume and pattern of antimicrobial consumption across human medicine, agriculture, and the environment. Stewardship arose as one of the principal responses recommended by professional societies and public-health bodies, and the consumption of antimicrobials is now routinely tracked at hospital, national, and international levels as a target for stewardship measurement.
Evidence & guidelines
The Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America issued foundational guidance for developing institutional stewardship programs in 2007 and a substantially expanded implementation guideline in 2016. A Cochrane systematic review (Davey et al., 2017) and a systematic review and meta-analysis of stewardship objectives (Schuts et al., 2016) summarise the supporting evidence base.
History
Concern about the misuse of antimicrobials dates to the earliest years of the antibiotic era, but stewardship as an organised institutional discipline crystallised in the 2000s, when accelerating resistance and a thinning drug-development pipeline prompted professional societies to formalise programmatic guidance. The 2007 IDSA/SHEA guideline established the template of a multidisciplinary program built around audit-and-feedback and formulary restriction, and the 2016 update broadened the evidence base and the menu of interventions.
Debates
- Restriction versus persuasion as the core stewardship strategy
- Restrictive interventions (preauthorization, formulary limits) can change prescribing quickly but may shift prescribing elsewhere and strain prescriber relationships, whereas persuasive interventions (audit and feedback, education) act more slowly; evidence supports both, and the optimal balance remains contested.
Related topics
Seminal works
- dellit-2007
- barlam-2016
- davey-2017
Frequently asked questions
- How does antimicrobial stewardship relate to antimicrobial resistance?
- Resistance is driven in large part by how antimicrobials are used; stewardship is the set of coordinated practices that aims to make that use appropriate, thereby reducing the selective pressure that promotes resistance.
- Is stewardship only about using fewer antibiotics?
- No. Stewardship promotes the optimal agent, dose, duration, and route for each situation, which sometimes means starting effective therapy promptly and sometimes means narrowing, shortening, or stopping it; the aim is appropriateness rather than reduction alone.